白雲山(00874.HK):原合夥人同意引入新興基金及工業基金公司作為沃博聯廣藥基金的新合夥人
格隆匯12月26日丨白雲山(00874.HK)公佈,於2023年12月25日,沃博聯廣藥基金原合夥人與新興基金及工業基金公司簽訂新合夥協議,據此,原合夥人同意引入新興基金及工業基金公司作為沃博聯廣藥基金的新合夥人並對合作協議所附的合夥協議進行相應修訂。新合夥協議中廣藥基金對沃博聯廣藥基金的出資金額、出資方式等核心條款均維持不變。
本次沃博聯廣藥基金新增有限合夥人、擴大規模是基金管理人在授權範圍內申請政府引導基金出資而實施的基金後續募集,不存在損害基金及原合夥人利益的情形。同時,公司出資設立的廣藥基金對沃博聯廣藥基金的出資金額、出資方式不變,不會對公司財務及經營狀況產生不利影響,不存在損害公司及中小股東利益的情況。廣藥基金出資設立沃博聯廣藥基金旨在加快公司對外投資步伐,發現和培育具備市場競爭力的優質標的,基金規模的擴大更助於上述目標的實現。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.